We are live on ! Find out more
MJN

Mead Johnson Nutrition Company
MJN

Delisted

MJN was delisted on the 14th of June, 2017.

450 hedge funds and large institutions have $13.9B invested in Mead Johnson Nutrition Company in 2013 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 164 increasing their positions, 154 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more call options, than puts

Call options by funds: $286M | Put options by funds: $203M

6% more repeat investments, than reductions

Existing positions increased: 164 | Existing positions reduced: 154

6% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 54

2% less funds holding

Funds holding: 458450 (-8)

5% less capital invested

Capital invested by funds: $14.7B → $13.9B (-$788M)

38% less funds holding in top 10

Funds holding in top 10: 138 (-5)

Holders
450
Holders Change
-8
Holders Change %
-1.75%
% of All Funds
14.59%
Holding in Top 10
8
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-38.46%
% of All Funds
0.26%
New
51
Increased
164
Reduced
154
Closed
54
Calls
$286M
Puts
$203M
Net Calls
+$83M
Net Calls Change
+$131M
Name Holding Trade Value Shares
Change
Change in
Stake
Verition Fund Management
301
Verition Fund Management
Connecticut
$782K +$538K +7,172 +213%
SBH
302
Segall Bryant & Hamill
Illinois
$773K
JG
303
Jefferies Group
New York
$737K +$206K +2,752 +38%
LMAM
304
Legg Mason Asset Management
Japan
$728K +$735K +9,800 New
V
305
Veritable
Delaware
$711K +$167K +2,221 +30%
B
306
Barings
North Carolina
$708K -$165K -2,200 -19%
Flossbach Von Storch
307
Flossbach Von Storch
Germany
$705K +$712K +9,500 New
CCA
308
Catalyst Capital Advisors
New York
$662K +$668K +8,910 New
Truist Financial
309
Truist Financial
North Carolina
$656K -$12K -160 -2%
BPBT
310
Boston Private Bank & Trust
Massachusetts
$646K -$16.7K -223 -2%
CI
311
Conning Inc
Connecticut
$641K +$9K +120 +1%
AL
312
AJO LP
Pennsylvania
$624K +$630K +8,400 New
MYLI
313
Meiji Yasuda Life Insurance
Japan
$608K -$52.9K -705 -8%
JMPWA
314
JP Morgan Private Wealth Advisors
California
$601K
SIM
315
Sentry Investment Management
Wisconsin
$579K +$217K +2,900 +59%
NB
316
Norinchukin Bank
Japan
$564K +$44.1K +588 +8%
PL
317
Parthenon LLC
Kentucky
$563K -$20.4K -272 -3%
RFS
318
Rockefeller Financial Services
New York
$558K
Teacher Retirement System of Texas
319
Teacher Retirement System of Texas
Texas
$553K +$74.8K +998 +15%
FFSOTS
320
Fiduciary Financial Services of The Southwest
Texas
$542K
AAM
321
Azzad Asset Management
Virginia
$541K
KRSITF
322
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$535K +$541K +7,211 New
CC
323
Cipher Capital
New York
$526K +$531K +7,087 New
TRCT
324
Tower Research Capital (TRC)
New York
$525K +$462K +6,164 +683%
FWIA
325
Fort Washington Investment Advisors
Ohio
$512K +$11.2K +150 +2%

MJN Hedge Fund Activity: Q3 2013 in Review

450 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Mead Johnson Nutrition Company (MJN) for Q3 2013, worth a combined $13.9B — down 5.4% from $14.7B a quarter earlier.

Sellers outnumbered buyers: 54 funds closed out of MJN and 51 opened new positions — a net loss of 3 holders — while 154 trimmed existing stakes and 164 added.

The largest buyer was Capital Research Global Investors, adding an estimated $353M. The largest seller was Edgewood Management, cutting an estimated $146M.

  • 450 institutional investors held Mead Johnson Nutrition Company (MJN) as of Q3 2013, down from 458 in Q2 2013.
  • Funds reported $13.9B of Mead Johnson Nutrition Company stock for Q3 2013, down 5.4% quarter-over-quarter.
  • 51 funds opened new Mead Johnson Nutrition Company positions in Q3 2013 and 54 closed out, a net change of -3 holders.
  • The largest Mead Johnson Nutrition Company buyer in Q3 2013 was Capital Research Global Investors, an estimated $353M added.
  • The largest Mead Johnson Nutrition Company seller in Q3 2013 was Edgewood Management, an estimated $146M sold.

Based on aggregated 13F filings for Q3 2013.